These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29389730)

  • 21. Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children.
    Licari A; Brambilla I; Sacchi L; Marseglia G; Ciprandi G
    Respir Med; 2019 May; 151():118-120. PubMed ID: 31047107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes.
    Westerhof GA; Korevaar DA; Amelink M; de Nijs SB; de Groot JC; Wang J; Weersink EJ; ten Brinke A; Bossuyt PM; Bel EH
    Eur Respir J; 2015 Sep; 46(3):688-96. PubMed ID: 26113672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma.
    Nagasaki T; Matsumoto H; Kanemitsu Y; Izuhara K; Tohda Y; Horiguchi T; Kita H; Tomii K; Fujimura M; Yokoyama A; Nakano Y; Hozawa S; Ito I; Oguma T; Izuhara Y; Tajiri T; Iwata T; Ono J; Ohta S; Yokoyama T; Niimi A; Mishima M
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1449-52. PubMed ID: 25496105
    [No Abstract]   [Full Text] [Related]  

  • 24. Change in biomarkers of type-2 inflammation following severe exacerbations of asthma.
    Semprini R; Shortt N; Ebmeier S; Semprini A; Varughese R; Holweg CTJ; Matthews JG; Fingleton J; Weatherall M; Beasley R; Braithwaite I
    Thorax; 2019 Jan; 74(1):95-98. PubMed ID: 30021810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic?
    Yap E; Chua WM; Jayaram L; Zeng I; Vandal AC; Garrett J
    Intern Med J; 2013 Jan; 43(1):46-52. PubMed ID: 21790924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of infants and preschool children at risk for asthma: predictive scores and biomarkers.
    Wandalsen GF; Solé D; Bacharier LB
    Curr Opin Allergy Clin Immunol; 2016 Apr; 16(2):120-6. PubMed ID: 26807784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum.
    Crespo A; Giner J; Torrejón M; Belda A; Mateus E; Granel C; Torrego A; Ramos-Barbón D; Plaza V
    J Asthma; 2016 Jun; 53(5):459-64. PubMed ID: 26785727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation.
    Sampson AP; Pizzichini E; Bisgaard H
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S49-59; discussion S59-61. PubMed ID: 12532086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.
    Wagener AH; de Nijs SB; Lutter R; Sousa AR; Weersink EJ; Bel EH; Sterk PJ
    Thorax; 2015 Feb; 70(2):115-20. PubMed ID: 25422384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sputum interleukin-13 as a biomarker for the evaluation of asthma control.
    Tsilogianni Z; Hillas G; Bakakos P; Aggelakis L; Konstantellou E; Papaioannou AI; Papaporfyriou A; Papiris S; Koulouris N; Loukides S; Kostikas K
    Clin Exp Allergy; 2016 Jul; 46(7):923-31. PubMed ID: 26990030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab?
    Amat F; Labbé A
    Expert Rev Respir Med; 2018 Jun; 12(6):475-482. PubMed ID: 29741411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exhaled nitric oxide measurements are not influenced by anti-eosinophil therapy in patients with asthma: A retrospective analysis.
    Ramonell RP; Lee FE; Levy JM; Kuruvilla M
    Ann Allergy Asthma Immunol; 2021 Jan; 126(1):102-104. PubMed ID: 32920056
    [No Abstract]   [Full Text] [Related]  

  • 33. [Asthma in clinical practice: from inflammatory phenotypes to personalized treatment].
    Schleich F; Graff S; Bougard N; Frix AN; Peerboom S; Demarche S; Guissard F; Paulus V; Henket M; Calmès D; Moermans C; Louis R
    Rev Med Liege; 2022 May; 77(5-6):289-294. PubMed ID: 35657185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthma.
    Arron JR; Choy DF; Scheerens H; Matthews JG
    Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S206-13. PubMed ID: 24313774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of asthma.
    Shute J
    Minerva Med; 2022 Feb; 113(1):63-78. PubMed ID: 34236156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype classification using the combination of lung sound analysis and fractional exhaled nitric oxide for evaluating asthma treatment.
    Shimoda T; Obase Y; Nagasaka Y; Asai S
    Allergol Int; 2018 Apr; 67(2):253-258. PubMed ID: 29066290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dupilumab in patients with uncontrolled asthma: type 2 biomarkers might be predictors of therapeutic efficacy.
    Yang D; Huang T; Liu B; Du Z; Liu C
    J Asthma; 2020 Jan; 57(1):79-81. PubMed ID: 30821528
    [No Abstract]   [Full Text] [Related]  

  • 38. Biomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease Control.
    Busse WW; Holgate ST; Wenzel SW; Klekotka P; Chon Y; Feng J; Ingenito EP; Nirula A
    Chest; 2015 Dec; 148(6):1489-1496. PubMed ID: 26226215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between exhaled inflammatory markers and asthma control in children.
    Van Vliet D; Smolinska A; Jöbsis Q; Rosias PP; Muris JW; Dallinga JW; van Schooten FJ; Dompeling E
    J Breath Res; 2016 Feb; 10(1):016014. PubMed ID: 26893372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children.
    Lanz MJ; Leung DY; White CW
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):161-4. PubMed ID: 10071519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.